Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | 2025-09-08 | 7,294 | $15.84 | $115.54kSell |
Christopher Yea | CHIEF DEVELOPMENT OFFICER | 2025-08-25 | 1,954 | $13.42 | $26.22kSell |
Nicole Sweeny | Chief Commercial Officer | 2025-08-25 | 1,480 | $13.42 | $19.86kSell |
Paul K. Audhya | CHIEF MEDICAL OFFICER | 2025-08-25 | 2,336 | $13.42 | $31.35kSell |
Christopher Yea | CHIEF DEVELOPMENT OFFICER | 2025-08-22 | 2,362 | $13.22 | $31.23kSell |
Paul K. Audhya | CHIEF MEDICAL OFFICER | 2025-08-22 | 2,942 | $13.22 | $38.90kSell |
Nicole Sweeny | Chief Commercial Officer | 2025-08-22 | 1,864 | $13.22 | $24.65kSell |
Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | 2025-08-22 | 10,940 | $13.22 | $144.66kSell |
Benjamin L. Palleiko | CHIEF EXECUTIVE OFFICER | 2025-08-18 | 4,409 | $13.19 | $58.14kSell |
Christopher Yea | CHIEF DEVELOPMENT OFFICER | 2025-08-18 | 2,649 | $13.19 | $34.93kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Vivo Ventures VI LLC | 16.64% | 8,409,126 | $113.52M | Insider |
Vr Adviser LLC | 13.32% | 6,728,985 | $90.84M | Institution |
Venrock Healthcare Capital Partners III LP | 10.50% | 5,303,985 | $71.60M | Insider |
Suvretta Capital Management LLC | 9.81% | 4,955,000 | $66.89M | Institution |
Tang Capital Management LLC | 9.78% | 4,941,798 | $66.71M | Institution |
Frazier Life Sciences Management LP | 9.67% | 4,887,867 | $65.99M | Institution |
Vestal Point Capital LP | 9.25% | 4,675,000 | $63.11M | Institution |
Interwest Management Partners IX LLC | 9.14% | 4,619,196 | $62.36M | Insider |
Guy P. Nohra | 8.60% | 4,343,550 | $58.64M | Insider |
Acmp IV LLC | 8.60% | 4,343,550 | $58.64M | Insider |